ArticleAnnals of transplantation2021

Safety of Antithymocyte Globulin Use in Kidney Graft Recipients During the COVID-19 Pandemic.

Aureliusz Kolonko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.